Globalance Footprint
of
Varian Medical Systems
Profile
In 2017, Varian became a dedicated cancer management company. The X-ray imaging business that had represented 20% of the business was spun off as the stand-alone Varex Imaging Corporation.
Footprint overview
Varian is increasingly developing devices and software for radiation therapies that can also be used in emerging and developing countries. Their new Access to Medicine Foundation is dedicated to educating specialists worldwide.
Footprint Score:
69 Points of 100
Footprint according to Themes
The Footprint of Varian is determined by the following Impacts:
Economy
Society
-
Nutrition
0/0
-
Health
41
41/60
-
Education and Knowledge
0/0
Environment
-
Biodiversity and Land
0/0
-
Resources and Climate
15
15/15
-
Water
0/0
adverse MSCI World43
Balanced 100
positive
Keys:
- Colors indicate Footprint Themes
- Length of bars indicate impact contribution per theme
- Actual/Max-column compares for each theme the actual scores to the maximum achievable in this sector or asset class. 0/0 stands for a theme not assessed.
The most important themes
The following themes contribute the most to the positive footprint of Varian:
-
Health
- Access to affordable healthcare
- Diversity of therapies, also for rare diseases
- New business models for healthcare providers
-
Resources and Climate
- Foster renewable energy sources
- Heightens energy efficiency
- Reduces CO2 emissions
- Foster renewable energy sources
-
Markets and Infrastructure
- Reduced corruption
- Highly developed financial markets
- Puts in place
sustainable infrastructure for energy, transport and communication
- Reduced corruption
Did you know
Varian has launched VitalBeam™, a cost-effective and upgradable image guided radiotherapy system. It is part of the innovative TrueBeam platform. The new product allows cost-constrained hospitals, especially in developing countries, to access advanced technology, to offer curative treatments for various cancer types and expand their general treatment capabilities over time.
Selected Footprint Facts
Some 30% of all cancers are lung cancers and the World Health organization estimates that in a few years’ time there will be more lung cancer patients in China alone than there are currently cancer cases in the rest of the world combined.
Varian has more than 1,000 active and pending patents around the world. Annually, Varian files dozens of patent applications based on continuing innovation.
Given the lack of qualified staff in developing countries to manage treatments and run the equipment correctly, Varian has been organizing “Access to Care” training programs for oncologists and physicists in Vietnam, South Africa or Algeria.
Source: Varian Medical Systems
As a cancer-fighting company, we are increasing our efforts to make the treatment of cancer more effective, affordable, and accessible for patients around the world.
Dow Wilson.
Dow Wilson
CEO
Source: Varian Medical Systems
Revenue By Region
- North America 43%
- Europe 30%
- Asia-Pacific 23%
Revenue By Business
- Oncology Systems 77%
- X-Ray Products 18%
- Other 5%
Source: Varian Medical Systems